Cardinal Health Inc. (NYSE: CAH) closed the day trading at 67.79 down -0.60% from the previous closing price of $68.20. In other words, the price has decreased by $-0.41 from its previous closing price. On the day, 3103071 shares were traded. CAH reached its highest trading level at $68.31 during the session, while it also had its lowest trading level at $67.30.
For a better understanding of CAH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.03. For the most recent quarter (mrq), Quick Ratio is recorded 0.60 and its Current Ratio is at 1.10.
Upgrades & Downgrades
Evercore ISI Upgraded its In-line to Outperform on May 18, 2022, whereas the target price for the stock was revised from $55 to $68.
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 when Snow Ola M sold 10,000 shares for $49.17 per share. The transaction valued at 491,700 led to the insider holds 36,969 shares of the business.
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.10.
Stock Price History:
Over the past 52 weeks, CAH has reached a high of $72.28, while it has fallen to a 52-week low of $45.85. The 50-Day Moving Average of the stock is 64.07, while the 200-Day Moving Average is calculated to be 56.78.
Over the past 3-months, CAH traded about 2.74M shares per day on average, while over the past 10 days, CAH traded about 3.5M shares per day. A total of 273.00M shares are outstanding, with a floating share count of 271.20M. Insiders hold about 0.50% of the company’s shares, while institutions hold 89.60% stake in the company. Shares short for CAH as of Jul 14, 2022 were 6.54M with a Short Ratio of 2.30, compared to 7.69M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.40% and a Short% of Float of 2.77%.
Dividends & Splits
CAH’s forward annual dividend rate is 1.98, up from 1.94 a year ago. Against a Trailing Annual Dividend Yield of 2.84%, it implies a Forward Annual Dividend Yield of 3.37%. The stock’s 5-year Average Dividend Yield is 3.59.
Current recommendations for the stock of the company come from 11 analysts. On average, analysts expect EPS of $1.17 for the current quarter, with a high estimate of $1.2 and a low estimate of $1.13, while EPS last year was $0.77. The consensus estimate for the next quarter is $1.21, with high estimates of $1.26 and low estimates of $1.17.
Analysts are recommending an EPS of between $5.21 and $5.15 for the fiscal current year, implying an average EPS of $5.19. EPS for the following year is $5.39, with 14 analysts recommending between $5.75 and $5.1.
9 analysts predict $44.71B in revenue for the current quarter. It ranges from a high estimate of $47.02B to a low estimate of $43.25B. As of the current estimate, Cardinal Health Inc.’s year-ago sales were $42.59B, an estimated increase of 5.00% from the year-ago figure.
A total of 13 analysts have provided revenue estimates for CAH’s current fiscal year. The highest revenue estimate was $181.28B, while the lowest revenue estimate was $176B, resulting in an average revenue estimate of $178.66B. In the same quarter a year ago, actual revenue was $162.47B, up 10.00% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $187.53B in the next fiscal year. The high estimate is $194.74B and the low estimate is $182.42B. The average revenue growth estimate for next year is up 5.00% from the average revenue estimate for this year.